articleThe Lancet OncologyJan 15, 2015GREEN OA

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Washington University in St. Louis · RTOG Foundation · +13 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,997
total citations
FWCI
159.10
Percentile
100%
References
27
Citations per year

Authors

22

Topics & keywords

Keywords
  • Carboplatin
  • Medicine
  • Cetuximab
  • Paclitaxel
  • Oncology
  • Radiation therapy
  • Stage (stratigraphy)
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding